Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Non-Current Assets (2016 - 2025)

Wave Life Sciences' Non-Current Assets history spans 11 years, with the latest figure at $23.7 million for Q4 2025.

  • For Q4 2025, Non-Current Assets fell 25.55% year-over-year to $23.7 million; the TTM value through Dec 2025 reached $23.7 million, down 25.55%, while the annual FY2025 figure was $23.7 million, 25.55% down from the prior year.
  • Non-Current Assets reached $23.7 million in Q4 2025 per WVE's latest filing, down from $25.9 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $53.2 million in Q2 2022 to a low of $23.7 million in Q4 2025.
  • Average Non-Current Assets over 5 years is $40.0 million, with a median of $41.9 million recorded in 2021.
  • Peak YoY movement for Non-Current Assets: crashed 45.82% in 2021, then rose 17.76% in 2022.
  • A 5-year view of Non-Current Assets shows it stood at $44.4 million in 2021, then grew by 7.66% to $47.8 million in 2022, then dropped by 17.29% to $39.6 million in 2023, then fell by 19.62% to $31.8 million in 2024, then decreased by 25.55% to $23.7 million in 2025.
  • Per Business Quant, the three most recent readings for WVE's Non-Current Assets are $23.7 million (Q4 2025), $25.9 million (Q3 2025), and $28.8 million (Q2 2025).